NewAmsterdam Pharma Company NV Warrant
Price & Volume
Stats
See more52W Range | $5.45-$19.19 |
Shares Short | 2,046 |
Financials
See moreRevenue (12 Mos) | $64M |
Revenue Growth (YoY) | 740.1% |
Gross Profit (12 Mos) | $64M |
Diluted EPS | $0 |
News
See moreYahoo Finance • 2 months ago
NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025
Yahoo Finance • 2 years ago
NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer
Yahoo Finance • 2 years ago
NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
About
CEO | Dr. Michael Harvey Davidson FACC, Facp., M.D. |
Address | Gooimeer 2-35, Naarden, Netherlands, 1411 DC |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |
